Methods and compositions for pretargeted immunotherapy
US11879010B2 · kind B2 · utility
0Cited by
11References
12Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Sep 23, 2022 |
| Grant date | Jan 23, 2024 |
| Priority date | — |
| Expiry date | Sep 23, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/732
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to methods and compositions comprising antibodies or fragments thereof comprising a targeting ligand and engineered cytotoxic cells comprising a targeting agent specific for the targeting ligand, for use in inducing cytotoxicity in a cancer cell, in delivering a cytotoxic cell to a cancer cell in a subject, and in treating cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.